Piramal Healthcare targets $2 bn revenue by FY30, to focus on organic expansion: Chairperson Nandini Piramal
Piramal Healthcare prioritizes organic growth for the next 4-5 years. The company will explore licensing and product acquisitions in complex generics and consumer healthcare. Piramal aims for $2 billion revenue by FY30, focusing on differentiated offerings like antibody-drug conjugates. Expansion includes investments in US facilities. The company reported Q1 FY26 results with a net loss of Rs 82 crore.
RSS News
Economic times
0 thoughts on “Piramal Healthcare targets $2 bn revenue by FY30, to focus on organic expansion: Chairperson Nandini Piramal”
Leave a Reply
Your email address will not be published. Required fields are marked *
RECENT NEWS
- Shah Rukh Khan Vs Salman Khan: One King, the other Sultan, both superstars, know who is more rich between Salman and Shah Rukh
- 'Reason he can't stand up to Trump is ...': Rahul's fresh charge at PM; claims 'Modi's hands are tied'
- Parliament logjam over SIR: Congress says discussion on 'votebandi' non-negotiable; asks why ignore Dhankar's 2023 ruling?
- Why is India buying so much war equipment worth Rs 67,000 crore? Missiles, aircraft, drones, and more
- 'Will call PM Modi': Brazil's Lula snubs Trump amid tariff row; rejects offer to reach out
